G GAIN THERAPEUTICS INC
| Market Cap | $78.60M |
| P/E Ratio | — |
| Forward P/E | -2.97 |
| Dividend Yield | — |
| Beta | 0.11 |
| 52W Range | $1.44 - $4.18 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Biotechnology |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| David Einhorn DME Capital Management | 0.06% | $1.82M | 566,130 | Buy |
Frequently Asked Questions
What is GANX stock price today?
GAIN THERAPEUTICS INC (GANX) is currently trading at $1.85. The stock has a 52-week range of $1.44 to $4.18 and a market capitalization of $78.60M.
Is GANX a good stock to buy in 2026?
GAIN THERAPEUTICS INC has a P/E ratio of N/A (forward P/E: N/A), a dividend yield of none, and 1-year performance of +3.4%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling GANX stock?
There have been 0 insider transactions for GANX in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has GANX stock performed over the past year?
GAIN THERAPEUTICS INC (GANX) has returned +3.4% over the past 12 months. The stock traded between $1.44 and $4.18 during this period, and is currently at $1.85.
Which hedge funds own GANX (GAIN THERAPEUTICS INC)?
1 tracked hedge funds currently hold GANX in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is GANX's market cap and valuation?
GAIN THERAPEUTICS INC (GANX) has a market capitalization of $78.60M. The trailing P/E ratio is N/A and forward P/E is N/A. The stock is classified in the Healthcare sector.
What is GANX's revenue and profitability?
GAIN THERAPEUTICS INC reported revenue of N/A with net income of N/A and a profit margin of N/A. The stock has a beta of 0.11.
What sector is GANX in and who are its biggest institutional holders?
GAIN THERAPEUTICS INC (GANX) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.